Although the discriminative ability of serum insulin alone was moderate, this performance remains meaningful for clinical application, as NAFLD is a multifactorial metabolic disease and a single biomarker cannot fully capture all relevant determinants. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.